In the latest Citeline’s Scrip Asks series, our Chief Scientific Officer, Francis Burrows, Ph.D., discusses how a new era in combination therapy has the potential to deliver better treatment options and transform #cancer care in 2025. Eleanor Malone https://bit.ly/4hB36X2
Editor in Chief, Commercial Insights at Citeline
1moThank you Kura Oncology, Inc. and Francis Burrows for contributing to our forward-looking series. There is so much progress to celebrate and even more to look forward to!